SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-21-000017
Filing Date
2021-05-13
Accepted
2021-05-13 16:21:04
Documents
66
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gale-20210331.htm   iXBRL 10-Q 921164
2 EX-31.1 sls20210331ex311.htm EX-31.1 8297
3 EX-31.2 sls20210331ex312.htm EX-31.2 8301
4 EX-32.1 sls20210331ex321.htm EX-32.1 6710
10 gale-20210331_g1.jpg GRAPHIC 30719
  Complete submission text file 0001390478-21-000017.txt   4915480

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20210331.xsd EX-101.SCH 43102
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20210331_cal.xml EX-101.CAL 66471
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20210331_def.xml EX-101.DEF 171693
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20210331_lab.xml EX-101.LAB 469129
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20210331_pre.xml EX-101.PRE 306439
11 EXTRACTED XBRL INSTANCE DOCUMENT gale-20210331_htm.xml XML 759659
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 21919948
SIC: 2834 Pharmaceutical Preparations